Le Lézard
Classified in: Health, Science and technology
Subjects: Contract/Agreement, Product/Service, Nonprofit, Business Update, Company Name Change

Ventegra, Inc. Announces Transition Into California Nonprofit Public Benefit Corporation ? Launch of Ventegra Foundation Aligned With Ventegra's 100-Year Strategy


Ventegra, Inc., a Medical Benefit Manager (MBM) that delivers innovative, cost-efficient pharmaceutical solutions to payors, providers, and patients, announces that it began its historic transition January 3, 2024, from being a California Benefit Corporation into Ventegra Foundation, a California Nonprofit Public Benefit Corporation. The State of California has previously approved the issuance of the Articles of Incorporation for Ventegra Foundation, and it is expected to be fully operational by June 30, 2024.

Robert T. Taketomo, Pharm.D., MBA, President & CEO of Ventegra, Inc., and Chairman of the Board of the Ventegra Foundation, says, "With this move, Ventegra, Inc. has initiated our ?100-year strategy' to move into a more sustainable and reliable healthcare solution for the community we serve."

Explaining the significance of this decision to obtain nonprofit status, Ventegra Board Member Larry L. Georgopoulos, Pharm.D., Ph.C., Emeritus Associate Dean of Clinical Affairs and Professor of Pharmacy Practice and Administrative Sciences, University of New Mexico, College of Pharmacy, says, "This launch represents an innovative break from the status quo in the administration of healthcare and pharmaceutical benefits. Ventegra Foundation will be strategically positioned to build on Ventegra, Inc.'s established track record and commitment of creating value and innovation for all stakeholders (payors, providers, and patients) in the communities we serve."

Ventegra Foundation Board Member Edward P. Kammerer, MD, Chief Quality Officer, Mosaic Life Care, Saint Joseph, Missouri, aptly sums up the value proposition of this new entity, explaining, "As a Nonprofit Public Benefit Corporation, Ventegra Foundation will have no obligation to shareholder earnings nor the risk of being flipped into a private equity or venture capital group. Instead, Ventegra Foundation will be governed by a Board of Directors, the majority of whom are selected by public charities, for the benefit of the communities served."

"This is a proud moment in Ventegra's history," says Dr. Taketomo. He explains, "Transitioning our operations into a nonprofit corporation on our 20th year of business represents a significant milestone for our company, our employees, our clients, the patients and providers we serve, and all of our stakeholders."

Adds Dr. Taketomo, "This is an important step toward improving the American healthcare system as a whole. By providing a more accessible and efficient not-for-profit solution in an industry plagued by oligopolies that are hurting consumers, perverse incentives, conflicts of interest and inertia, Ventegra Foundation will set a new standard for integrity in the administration of healthcare and pharmaceutical benefits."

Further detailing the significance of this milestone achievement, Ventegra Foundation Board Member Guy L. Clifton, MD, CEO and Founder of Actin Care Groups, Crystal Lake, IL, states, "Ventegra has a unique business model that is not predicated on a fiduciary responsibility to generate returns for shareholders; instead, Ventegra can focus on meeting the needs of the patients and the community that it serves. Ventegra supports programs that a traditional Pharmacy Benefits Manager (PBM) will not because of the conflicts of interest that are endemic in healthcare administrative services. The new Ventegra Foundation is uniquely positioned to change that dynamic at scale."

About Ventegra, Inc.

Ventegra, Inc. is the legacy Ventegra that is dedicated to servicing Ventegra Foundation. Over time, the assets of Ventegra, Inc. will transition over to Ventegra Foundation. www.ventegra.com

About Ventegra Foundation

Ventegra Foundation is a California Nonprofit Public Benefit Corporation. Its mission is to establish new channels for delivering better efficiencies and more cost-effective healthcare for the community that is served. A complex transition process will be initiated that will transfer the intellectual property and personnel of Ventegra, Inc. into Ventegra Foundation. The implementation process is expected to be completed by June 30, 2024. www.ventegra.com


These press releases may also interest you

at 06:00
The report "Anti-Migrating Agent Market by Type (Non-ionic, Anionic, Cationic, Amphoteric), Grades (Technical, Food, Pharmaceutical), Application, Chemistry (Organic, Inorganic), End-Use Industry (Textile, Plastics, Paper), and Region - Global...

at 05:42
Gupshup, the world's leading Conversation Cloud, in collaboration with Meta, the Sudan Medical Specialization Board and non-profit Shabaka today announced the launch of a telemedicine chatbot providing healthcare access for Sudanese refugees in...

at 05:23
The revenue in June for Zinzino's sales markets increased by 13% and amounted to SEK 148.5 (131.4) million. Faun Pharma's external sales decreased and amounted to SEK 5.8 (8.5) million. Overall, the Group increased revenues by 10% to SEK 154.3...

at 05:00
The global Specialty Enzymes Market size is estimated to be valued at USD 6.1 billion in 2024 and is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5% from 2024 to 2029 according to a report published by MarketsandMarketstm. The...

at 05:00
Kvantify, a leading quantum software start-up, has announced the successful closure of a EUR 10 million seed round. This funding will enable Kvantify to strengthen its position as a global leader in quantum computing, with an initial focus on...

at 04:37
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cytotoxic Drugs and HPAPI Manufacturing  Market- (Type of Product (HPAPI and highly potent finished dosage form), Company Size (Small, Mid-sized, Large,...



News published on and distributed by: